Categories: Africa

Two new Ebola vaccines to join DR Congo clinical trial



The announcement by the UN World Health Organization (WHO) follows the recommendation of its independent Technical Advisory Group on Candidate Vaccines Prioritization. 

This will mark the first time that vaccines specifically designed for Bundibugyo virus will be evaluated during an outbreak of the disease. 

“The fact that these vaccines are ready to enter clinical trials is a testament to the power of science and partnership,” said WHO Director-General Tedros Adhanom Ghebreyesus. 

He stressed that while vaccines alone will not end the outbreak, “they could become a powerful new tool for bringing it under control”. 

‘Hope’ as cases mount

The two vaccine candidates are ChAdOx1, developed by the University of Oxford with the Serum Institute of India, and mRNA-1469, developed by the American pharmaceutical and biotech company Moderna. 

WHO convened the expert group which this week recommended them for further clinical evaluation, based on available evidence.  

The DRC has been battling a deadly outbreak of Ebola disease caused by the rare Bundibugyo virus species for nearly six months and it has become the largest in the country’s history.  As of 1 November, there were more than 10,500 confirmed cases and 5,126 deaths. 

WHO is supporting the Tumaini multi-vaccine trial, named after the Swahili word for “hope”. It was launched on 23 October in the eastern city of Bunia, capital of Ituri province, which remains the epicentre of the outbreak.  

The Ervebo vaccine, used to treat the Zaire species of the Ebola virus, is already being tested to determine if it is effective against Bundibugyo species. The two new vaccine candidates will enter the trial following national approvals. 

Tumaini is designed to test multiple vaccine candidates within a single trial, using a ring-vaccination approach that focuses on contacts of people with confirmed Ebola Bundibugyo.  

WHO and partners pioneered the strategy during the West Africa Ebola outbreak a decade ago, where a trial in Guinea established the efficacy of the Ervebo vaccine. 

Four vaccination rings have been set up and several more are being prepared, while research into other potential treatments is also moving forward. 



Source link

gulftimes

Recent Posts

Arab News | Ancient Egyptian burial site gives up its priceless secrets

CAIRO: Archaeologists have uncovered an ancient necropolis in northern Egypt containing a priceless treasure trove…

6 minutes ago

Arab News | Syria hails historic UN resolution recognizing post-war progress

NEW YORK: Syria’s Permanent Representative to the UN, Ibrahim Olabi, said the UN General Assembly…

9 minutes ago

Arab News | Journey of trust takes blind Saudi adventurer to Everest Base Camp

JEDDAH: For nine days, Rashad Naqeeb crossed rocky trails, icy paths and steep mountain passes…

56 minutes ago

Arab News | Saudi Arabia among 16 countries backing UK and Australian sanctions on Israeli settlement expansion

RIYADH: Saudi Arabia and 15 other countries welcomed sanctions imposed this week by the UK…

1 hour ago

Cartoon by Amjad Rasmi. (Courtesy of Asharq Al-Awsat)

Cartoon by Amjad Rasmi. (Courtesy of Asharq Al-Awsat) Source link

1 hour ago

Arab News | Injury ends Erik van Rooyen’s bid for conditional PGA Tour status

WASHINGTON: Erik van Rooyen withdrew from the RSM Classic with a rib injury on Thursday…

2 hours ago